A dual-modality quantitative phase and polarized light microscope to assess cell motility and extracellular matrix remodeling during invasion
A dual-modality quantitative phase and polarized light microscope to assess cell motility and extracellular matrix remodeling during invasion
批准号:
9924599
负责人:
Christopher B Raub
金额:
$7.95万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2022-02-28
关键词:
3-DimensionalActinsBiological AssayBiopsyBirefringenceBreast Cancer cell lineCaliberCalibrationCancer BiologyCancer ModelCancer cell lineCellsCessation of lifeCharacteristicsClinicalCollagenComplexConfocal MicroscopyDevelopmentDiseaseDose-LimitingEffectivenessEnvironmentExtracellular MatrixF-ActinFibrosisFutureGoalsHealthHolographyHourHydrogelsImageImmunofluorescence ImmunologicIn VitroInterstitial CollagenaseInvadedKnowledgeLabelLaser Scanning MicroscopyLengthLight MicroscopeLinkMDA MB 231Malignant NeoplasmsMapsMeasurementMicroscopeMicroscopyMicrospheresModalityModelingNeoplasm MetastasisNeural Tube DevelopmentOpticsPathologic ProcessesPhasePhenotypePhototoxicityPolarization MicroscopyPolystyrenesProcessProteinsPublishingResearchResourcesSamplingSignal TransductionSlideSolidSpecimenStainsStressSystemTestingTimeTissuesToxic effectWound modelsbasecancer cellcancer therapycell motilitycellular imagingdigitaldrug candidateflexibilitygastrulationimaging biomarkerimaging modalityin vitro Modelindexinginhibitor/antagonistinnovationinsightinstrumentmicroscopic imagingnon-invasive imagingnovelpolarized lightprognostic valuereconstructionscale upsuccesstargeted treatmenttherapeutic candidatethree-dimensional modelingtumor microenvironment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
7. Project Summary/Abstract
Cancer metastases are responsible for most deaths from the disease. However, most current cancer therapies
are anti-proliferative, rather than anti-metastatic. Challenges to the clinical realization of anti-metastatic
therapies include dose-limiting toxicity to non-cancer cells, effective targeting, effective timing of administration
given that metastasis is an early cancer process, and effectiveness in the face of adaptive invasion strategies
by cancer cells. An ideal platform to test anti-metastatic therapeutic candidates would mimic the tumor
microenvironment, and accurately assess cancer cell motile phenotypes as well as pro-invasion microstructural
signatures in the extracellular matrix.
This proposal aims to 1) develop a dual-modality quantitative phase and polarized light microscopy system
capable of 2) evaluating the effects of inhibitors of matrix invasion and microenvironmental factors on the
spread of cancer cells in a tissue-like in vitro environment. Quantitative optical indices from the proposed
system accurately assess cell phenotype and microstructural signatures of invasion, by evaluating cell phase
and matrix birefringence signals. These imaging modalities also deliver low optical power to the sample,
allowing for long-term, serial microscopy without phototoxic effects on cancer cell movement. Finally, an
innovative but simple culture set-up creates collagen networks with alignment and pre-stress similar to the
tumor microenvironment. Steps to achieve these aims include addition of polarizing optics to an existing digital
holographic microscope, signal calibration, channel co-registration, and initial time-lapse imaging of an in vitro
3D model of cancer invasion. Optical indices of invasion will be evaluated in a scaled-up study.
After installing a second camera and full polarization state generator and analyzer on the existing digital
holographic microscope, phase and birefringence signals will be evaluated and co-registered using a
polystyrene microsphere standard (n=1.59) set in solid mounting media (n=1.52). Phase and polarized light
parameters will be calibrated by computing phase maps of standard beads of fixed diameter, and optical
retardance of a zero-order waveplate. The invasion of the breast cancer cell line MDA-MB-231 will be
evaluated from serial time-lapse imaging over 24 hours, in the presence and absence of 30 nM chondramide,
an actin-stabilizing anti-metastatic therapeutic candidate. The effects of pre-stress and extracellular matrix
alignment will also be evaluated.
The health-relatedness of this proposal lies in development of a quantitative phase and polarized light
microscope that computes parameter maps for invading cancer cells and their microenvironmental
surroundings. The proposed microscope reduces phototoxicity and provides quantitative metrics for accurate
assessment of the mechanisms and aggressiveness of cancer cell invasion, thus enabling testing of anti-
metastatic drug candidates.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
A high throughput, in vitro screening system for treatments of oral mucositis in cancer
-
批准号:10041746
-
项目类别:
-
资助金额:$14.66万
-
财政年份:2020
-
负责人:Christopher B Raub
-
依托单位:
A high throughput, in vitro screening system for treatments of oral mucositis in cancer
-
批准号:10251272
-
项目类别:
-
资助金额:$14.45万
-
财政年份:2020
-
负责人:Christopher B Raub
-
依托单位:
Controlling chondrocyte matrix degradation and repair in 3-D culture.
-
批准号:7807636
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2010
-
负责人:Christopher B Raub
-
依托单位:
Controlling chondrocyte matrix degradation and repair in 3-D culture.
-
批准号:8035903
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2010
-
负责人:Christopher B Raub
-
依托单位:
Controlling chondrocyte matrix degradation and repair in 3-D culture.
-
批准号:8213730
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2010
-
负责人:Christopher B Raub
-
依托单位:
Multiphoton Imaging and Rheology of Fibrosis Models
-
批准号:7407804
-
项目类别:
-
资助金额:$3.13万
-
财政年份:2007
-
负责人:Christopher B Raub
-
依托单位:
Multiphoton Imaging and Rheology of Fibrosis Models
-
批准号:7496521
-
项目类别:
-
资助金额:$3.18万
-
财政年份:2007
-
负责人:Christopher B Raub
-
依托单位:
海外基金